“However, the oxidation of a non-CPT 1 dependent substrate palmitoylcarnitine was unaffected by adriamycin except … than 1 mM. These data suggest that after in vitro or in vivo administration, adriamycin , inhibits fatty acid oxidation in part secondary to … 1 and/or depletion of its substrate, L-carnitine , in ….”
“Interestingly, medium- and short-chain fatty acid oxidation, which are independent of CPT 1, were also inhibited acutely by adriamycin and could be reversed by L-carnitine.”